Completed Clinical Trials

Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

By April 24, 2017 No Comments


Malignant Mesothelioma

Estimated Enrollment: 60

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Primary Purpose: Treatment

Study ID Numbers: CDR0000564058|COL-ALIMESO|INCA-RECF0441|COL-2006-04

Study First Received: October 5, 2007

Last Updated: May 14, 2011

Estimated Primary Completion Date: May 2011


Primary Outcome Measures:

Individual dosage-adapted protocol|Relationship between pharmacokinetic and pharmacodynamic parameters|Pharmacokinetics|Pharmacogenetic variations (MTHFR, TS, GSTpi, ERCC1, XPD)

Sponsors and Collaborators:

Centre Oscar Lambret|National Cancer Institute (NCI)

Website Link:

Leave a Reply

Call Now ButtonCall Now